000			01965 a2200541 4500
005			20250516095007.0
264		0	_c20121130
008			201211s 0 0 eng d
022			_a1873-7064
024	7		_a10.1016/j.neuropharm.2012.05.042 _2doi
040			_aNLM _beng _cNLM
100	1		_aFoley, Andrew G
245	0	0	_aClass I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder. _h[electronic resource]
260			_bNeuropharmacology _cSep 2012
300			_a750-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aChild
650	0	4	_aChild Development Disorders, Pervasive _xdrug therapy
650	0	4	_aCognition Disorders _xetiology
650	0	4	_aDentate Gyrus _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aHistone Deacetylase 1 _xantagonists & inhibitors
650	0	4	_aHistone Deacetylase Inhibitors _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNerve Tissue Proteins _xmetabolism
650	0	4	_aNeural Cell Adhesion Molecule L1 _xmetabolism
650	0	4	_aNeuronal Plasticity _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aPregnancy
650	0	4	_aPrenatal Exposure Delayed Effects
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSialic Acids _xmetabolism
650	0	4	_aSocial Behavior
700	1		_aGannon, Shane
700	1		_aRombach-Mullan, Nanette
700	1		_aPrendergast, Alison
700	1		_aBarry, Claire
700	1		_aCassidy, Andrew W
700	1		_aRegan, Ciaran M
773	0		_tNeuropharmacology _gvol. 63 _gno. 4 _gp. 750-60
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2012.05.042 _zAvailable from publisher's website
999			_c21851438 _d21851438